Navigation Links
InVitria's Better Ingredients for Better Media to be Showcased at BPI '09
Date:10/1/2009

InVitria's new cell culture media supplements, Zap-CHO and Optiferrin, have been developed to maximize cell culture media performance and will be on display at BioProcess International '09, the premier event for the bioprocessing industry, October 12-16 at Raleigh Convention Center in Raleigh, North Carolina.

Fort Collins, CO (PRWEB) October 1, 2009 -- As conference exhibitor and poster presenter, InVitria will highlight the recent launch of two new products -- Zap-CHO and Optiferrin. These products add to InVitria's product line and will be part of its "Better Ingredients for Better Media" promotion at BPI '09.

InVitria's media supplements are gaining significant traction in the cell culture media and biomanufacturing industry and will be on display at BioProcess International Conference and Exhibition in Raleigh, North Carolina, October 12-16.

Further, InVitria will be hosting a pizza party where attendees can learn more about InVitria's completely animal free and high performance product line. Visitors to InVitria's exhibit booth #1011 can pick up an invitation to the pizza party and learn more about InVitria's exciting product line.

Zap-CHO
Zap-CHO is a defined and animal free CHO (Chinese hamster ovaries) cell culture supplement capable of replacing fetal bovine serum (FBS) while still maintaining maximum cell performance. Zap-CHO is also an alternative to using hydrolysates in cell culture media optimization because it is a well-defined supplement which reduces variability and production failures. Zap-CHO is ideal for use with commercial, chemically-defined and serum- and animal free cell culture media formulations.

Optiferrin
Optiferrin is a cell culture media supplement which supports cell growth by regulating the amount of iron transported to the cell. Since iron is required for healthy cell culture performance, it is a critical component to reach optimal performance. InVitria's Optiferrin is animal free, so it is a safe and effective alternative to using iron chelators and elemental iron in media formulations. InVitria customers have utilized Optiferrin to provide the essential amount of iron for optimal results.

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's newest products, Zap-CHO and Optiferrin, and to order InVitria products please contact InVitria at info(at)invitria(dot)com or call 1-800-916-8311. Orders may be placed online using a credit card at www.InVitria.com.

###

Read the full story at http://www.prweb.com/releases/Zap-CHO/Optiferrin/prweb2974734.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
2. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
3. Older Women May Sleep Better Than Men
4. Study shows that elderly women sleep better than they think, men sleep worse
5. Pelosi: Health Reform Will Provide Seniors Better Benefits, Guaranteed Access to Doctors, Extended Stability for Medicare
6. Chronic pain treatments work better together, says anesthesiologist
7. Henry Ford Macomb Hospital Deploys PerfectServe at Warren Campus to Improve Communication, Better Coordinate Care
8. Sexually satisfied women have better general well-being and more vitality
9. Women fare better than men with metastatic colorectal cancer -- are hormones helping?
10. UNC expert: Better decision support tools needed for prostate cancer screening choice
11. Drug-eluting stents better than bare-metal stents for heart attack patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: